ROS accumulation by PEITC selectively kills ovarian cancer cells via UPR-mediated apoptosis

Yoon Hee Hong, Md Hafiz Uddin, Untek Jo, Boyun Kim, Jiyoung Song, Dong Hoon Suh, Hee Seung Kim, Yong Sang Song

Research output: Contribution to journalArticle

28 Citations (Scopus)

Abstract

Unfolded protein response (UPR) is crucial for both survival and death of mammalian cells, which is regulated by reactive oxygen species (ROS) and nutrient depletion. In this study, we demonstrated the effect of ROS-accumulation, induced by β-phenethyl isothiocyanate (PEITC), on UPR-mediated apoptosis in ovarian cancer cells. We used ovarian cancer cell lines, PA-1 and SKOV-3, with different p53 status (wild- and null-type, respectively). PEITC caused increased ROS-accumulation and inhibited proliferation selectively in ovarian cancer cells, and glutathione (GSH) depletion in SKOV-3. However, PEITC did not cause any effect in normal ovarian epithelial cells and peripheral blood mononuclear cells. After 48 h of PEITC treatment (5 μM), apoptotic cell death was shown to increase significantly in the ovarian cancer cells and not in the normal cells. The key regulator of UPR-mediated apoptosis, CHOP/GADD153 and endoplasmic reticulum resident chaperone BiP/GRP78 were parallely up-regulated with activation of two major sensors of the UPR [PERK and ATF-6 in PA-1; PERK, and IRE1a in SKOV-3) in response to ROS accumulation induced by PEITC (5 μM). ROS scavenger, N-acetyl-L-cysteine (NAC), attenuated the effect of PEITC on UPR signatures (P-PERK, IRE1a, CHOP/GADD153, and BiP/GRP78), suggesting the involvement of ROS in UPR-mediated apoptosis. Altogether, PEITC induces UPR-mediated apoptosis in ovarian cancer cells via accumulation of ROS in a cancer-specific manner.

Original languageEnglish
Article number167
JournalFrontiers in Oncology
Volume5
Issue numberJUL
DOIs
StatePublished - 1 Jan 2015

Fingerprint

Unfolded Protein Response
Ovarian Neoplasms
Reactive Oxygen Species
Apoptosis
Cell Death
Acetylcysteine
phenethyl isothiocyanate
Endoplasmic Reticulum
Glutathione
Blood Cells
Epithelial Cells
Cell Line
Food

Keywords

  • Apoptosis
  • Ovarian cancer
  • Reactive oxygen species
  • Unfolded protein response
  • β-phenethyl isothiocyanate

Cite this

@article{5fc0790b534a48cbb160072ded84394f,
title = "ROS accumulation by PEITC selectively kills ovarian cancer cells via UPR-mediated apoptosis",
abstract = "Unfolded protein response (UPR) is crucial for both survival and death of mammalian cells, which is regulated by reactive oxygen species (ROS) and nutrient depletion. In this study, we demonstrated the effect of ROS-accumulation, induced by β-phenethyl isothiocyanate (PEITC), on UPR-mediated apoptosis in ovarian cancer cells. We used ovarian cancer cell lines, PA-1 and SKOV-3, with different p53 status (wild- and null-type, respectively). PEITC caused increased ROS-accumulation and inhibited proliferation selectively in ovarian cancer cells, and glutathione (GSH) depletion in SKOV-3. However, PEITC did not cause any effect in normal ovarian epithelial cells and peripheral blood mononuclear cells. After 48 h of PEITC treatment (5 μM), apoptotic cell death was shown to increase significantly in the ovarian cancer cells and not in the normal cells. The key regulator of UPR-mediated apoptosis, CHOP/GADD153 and endoplasmic reticulum resident chaperone BiP/GRP78 were parallely up-regulated with activation of two major sensors of the UPR [PERK and ATF-6 in PA-1; PERK, and IRE1a in SKOV-3) in response to ROS accumulation induced by PEITC (5 μM). ROS scavenger, N-acetyl-L-cysteine (NAC), attenuated the effect of PEITC on UPR signatures (P-PERK, IRE1a, CHOP/GADD153, and BiP/GRP78), suggesting the involvement of ROS in UPR-mediated apoptosis. Altogether, PEITC induces UPR-mediated apoptosis in ovarian cancer cells via accumulation of ROS in a cancer-specific manner.",
keywords = "Apoptosis, Ovarian cancer, Reactive oxygen species, Unfolded protein response, β-phenethyl isothiocyanate",
author = "Hong, {Yoon Hee} and Uddin, {Md Hafiz} and Untek Jo and Boyun Kim and Jiyoung Song and Suh, {Dong Hoon} and Kim, {Hee Seung} and Song, {Yong Sang}",
year = "2015",
month = "1",
day = "1",
doi = "10.3389/fonc.2015.00167",
language = "English",
volume = "5",
journal = "Frontiers in Oncology",
issn = "2234-943X",
publisher = "Frontiers Media S.A.",
number = "JUL",

}

ROS accumulation by PEITC selectively kills ovarian cancer cells via UPR-mediated apoptosis. / Hong, Yoon Hee; Uddin, Md Hafiz; Jo, Untek; Kim, Boyun; Song, Jiyoung; Suh, Dong Hoon; Kim, Hee Seung; Song, Yong Sang.

In: Frontiers in Oncology, Vol. 5, No. JUL, 167, 01.01.2015.

Research output: Contribution to journalArticle

TY - JOUR

T1 - ROS accumulation by PEITC selectively kills ovarian cancer cells via UPR-mediated apoptosis

AU - Hong, Yoon Hee

AU - Uddin, Md Hafiz

AU - Jo, Untek

AU - Kim, Boyun

AU - Song, Jiyoung

AU - Suh, Dong Hoon

AU - Kim, Hee Seung

AU - Song, Yong Sang

PY - 2015/1/1

Y1 - 2015/1/1

N2 - Unfolded protein response (UPR) is crucial for both survival and death of mammalian cells, which is regulated by reactive oxygen species (ROS) and nutrient depletion. In this study, we demonstrated the effect of ROS-accumulation, induced by β-phenethyl isothiocyanate (PEITC), on UPR-mediated apoptosis in ovarian cancer cells. We used ovarian cancer cell lines, PA-1 and SKOV-3, with different p53 status (wild- and null-type, respectively). PEITC caused increased ROS-accumulation and inhibited proliferation selectively in ovarian cancer cells, and glutathione (GSH) depletion in SKOV-3. However, PEITC did not cause any effect in normal ovarian epithelial cells and peripheral blood mononuclear cells. After 48 h of PEITC treatment (5 μM), apoptotic cell death was shown to increase significantly in the ovarian cancer cells and not in the normal cells. The key regulator of UPR-mediated apoptosis, CHOP/GADD153 and endoplasmic reticulum resident chaperone BiP/GRP78 were parallely up-regulated with activation of two major sensors of the UPR [PERK and ATF-6 in PA-1; PERK, and IRE1a in SKOV-3) in response to ROS accumulation induced by PEITC (5 μM). ROS scavenger, N-acetyl-L-cysteine (NAC), attenuated the effect of PEITC on UPR signatures (P-PERK, IRE1a, CHOP/GADD153, and BiP/GRP78), suggesting the involvement of ROS in UPR-mediated apoptosis. Altogether, PEITC induces UPR-mediated apoptosis in ovarian cancer cells via accumulation of ROS in a cancer-specific manner.

AB - Unfolded protein response (UPR) is crucial for both survival and death of mammalian cells, which is regulated by reactive oxygen species (ROS) and nutrient depletion. In this study, we demonstrated the effect of ROS-accumulation, induced by β-phenethyl isothiocyanate (PEITC), on UPR-mediated apoptosis in ovarian cancer cells. We used ovarian cancer cell lines, PA-1 and SKOV-3, with different p53 status (wild- and null-type, respectively). PEITC caused increased ROS-accumulation and inhibited proliferation selectively in ovarian cancer cells, and glutathione (GSH) depletion in SKOV-3. However, PEITC did not cause any effect in normal ovarian epithelial cells and peripheral blood mononuclear cells. After 48 h of PEITC treatment (5 μM), apoptotic cell death was shown to increase significantly in the ovarian cancer cells and not in the normal cells. The key regulator of UPR-mediated apoptosis, CHOP/GADD153 and endoplasmic reticulum resident chaperone BiP/GRP78 were parallely up-regulated with activation of two major sensors of the UPR [PERK and ATF-6 in PA-1; PERK, and IRE1a in SKOV-3) in response to ROS accumulation induced by PEITC (5 μM). ROS scavenger, N-acetyl-L-cysteine (NAC), attenuated the effect of PEITC on UPR signatures (P-PERK, IRE1a, CHOP/GADD153, and BiP/GRP78), suggesting the involvement of ROS in UPR-mediated apoptosis. Altogether, PEITC induces UPR-mediated apoptosis in ovarian cancer cells via accumulation of ROS in a cancer-specific manner.

KW - Apoptosis

KW - Ovarian cancer

KW - Reactive oxygen species

KW - Unfolded protein response

KW - β-phenethyl isothiocyanate

UR - http://www.scopus.com/inward/record.url?scp=84940101852&partnerID=8YFLogxK

U2 - 10.3389/fonc.2015.00167

DO - 10.3389/fonc.2015.00167

M3 - Article

AN - SCOPUS:84940101852

VL - 5

JO - Frontiers in Oncology

JF - Frontiers in Oncology

SN - 2234-943X

IS - JUL

M1 - 167

ER -